Use access key #2 to skip to page content.
$2.99 0.07 (2.40%)
10/10/2008 4:00 PM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View Ticker Page (MNKD)

Results 51 - 60 of 70 : « Previous   67

Recs

0

Avatar liv1478 (< 20) Submitted: 6/11/07 8:16 PM : Outperform Start Price: $13.77 MNKD Score: -37.02

high increase in today's volume of stock and call options.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar HOPPER57 (47.30) Submitted: 6/08/07 12:59 PM : Outperform Start Price: $11.66 MNKD Score: -33.43

Good leadership H. Mann


Promising Technology


Pharma looking to get into the diabetes market, 52 week low??

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar LuckyGuest (47.13) Submitted: 6/08/07 11:10 AM : Outperform Start Price: $11.52 MNKD Score: -33.20

Unique solutions to medicine delivery.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ref788 (43.43) Submitted: 5/03/07 9:16 AM : Outperform Start Price: $14.53 MNKD Score: -38.43

upgraded but still near 52 week low... wtf?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar anylawn (< 20) Submitted: 4/11/07 4:55 PM : Outperform Start Price: $14.67 MNKD Score: -41.19

Great leadership in Alfred Mann.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ballhawker (57.05) Submitted: 8/22/07 5:28 PM : Outperform Start Price: $9.08 MNKD Score: -27.14

Mannkind has a stellar management group, led by Alfred Mann, has a product in Phase 3 trials that is expected to win FDA approval in Q3 or Q4 next year, and that product is expected to revolutionize how insulin is delivered as well as mimick the bodi...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Engineer4 (36.61) Submitted: 9/06/07 1:49 PM : Outperform Start Price: $9.59 MNKD Score: -28.60

Al Mann

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar iscmike (< 20) Submitted: 3/24/08 3:20 PM : Outperform Start Price: $6.02 MNKD Score: -15.79

This is a drug company that has an innovative product that will revolutionize diabetes (at least that's what I'm hoping for). Being a diabetic and having followed the research and trials of their product will be the best thing out there. Instead of...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar beary11 (48.85) Submitted: 3/08/08 1:13 PM : Outperform Start Price: $5.04 MNKD Score: -8.85

diabetes

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar fabdog7 (58.12) Submitted: 2/22/08 2:52 AM : Outperform Start Price: $7.07 MNKD Score: -23.28

if the insulin inhaled drug is approved... gangbusters... if not, it goes to zero...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners